Cat. No S57C4X-1039_1_MG
US-CATO

Product Information

Product Name
Donepezil
Brand Name
US-CATO
Product Number
C4X-1039
CAS
120014-06-4
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
3152
IUPAC Name
2-(1-benzylpiperidin-4-yl)methyl-5,6-dimethoxy-2,3-dihydroinden-1-one
InChI Key
ADEBPBSSDYVVLD-UHFFFAOYSA-N
SMILES
COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC

References Data Source From Pubchem

Correction: Tailoring treatments: pharmacogenomics in the management of neurodegenerative diseases

Publication Name: Acta Neurologica Belgica
Publication Date: 2026-06-15
DOI: 10.1007/s13760-025-02919-4|10.1007/s13760-026-03095-9

Exploring the Gut-Brain Connection: Are Probiotics the Next Frontier in Alzheimer’s Disease Treatment?

Publication Name: Probiotics and Antimicrobial Proteins
Publication Date: 2026-03-04
DOI: 10.1007/s12602-026-10927-w

Current advances in 7-hydroxycoumarin derivatives as potential therapeutic agents for Alzheimer’s disease

Publication Name: Molecular Diversity
Publication Date: 2026-03-04
DOI: 10.1007/s11030-026-11503-8

Functional and structural retinal alterations in Alzheimer’s disease: insights from photopic negative response (PhNR) and OCT-based analysis

Publication Name: Documenta ophthalmologica. Advances in ophthalmology
Publication Date: 2026-03-04
DOI: 10.1007/s10633-026-10089-8

Breaking the Barrier of Brain Disease Therapeutics: Advocating Targeted Drug Delivery for Improved Neuro-Resident Interventions

Publication Name: AAPS PharmSciTech
Publication Date: 2026-03-04
DOI: 10.1208/s12249-026-03386-7

Donepezil

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page